Chemxpert Database

Industry Updates

ChemXpert Database Highlights

Total No. of Buyers
Added
20000

Total No. of Suppliers
Added
5000

Total No. of New Products Added
20000

Total No. of New Contacts Added/Updated
25000

New Feature Added
Australian Approval

New Feature Added
European Approval

Mediation between Bayer, plaintiffs seeks to clarify all justified claims: U.S. mediator

Aurobindo Pharma plunges 9% as USFDA issues 14 observations

India-linked illegal steroid smuggling ring busted in UK

To cut insulin prices, WHO to certify generic versions

China's BeiGene gets FDA approval for drug to treat rare form of lymphoma

LEO Pharma, HitGen to develop novel class of derma drugs

LEO Pharma Exercises Option with HitGen to License Compounds for Development of Novel Class of Drugs in Dermatology

ESIC pharmacists to move SC for removal of medical professionals from holding charges of drug stores and pharmacies

Merz to create three independent, customer-focused healthcare businesses to drive growth

Mediation between Bayer, plaintiffs seeks to clarify all justified claims: U.S. mediator

Biogen and Samsung expand biosimilar deal to cover Lucentis, Eylea and China

Novartis GDD Centre in Hyderabad to support critical components of drug development process for patient safety

Protein could offer therapeutic target for pancreatic cancer

LFA develops online self-care management programmes to empower people with lupus

US FDA grants breakthrough therapy designation to F2G's olorofim

Oncology Pharma and Ribera Solutions Signed a Licensing Agreement for the Use of Ribera's Clinical Trials Platform, Connect2Med

China approves Alzheimer's drug

Unsuccessful in licensing talks, feds sue Gilead over PrEP-focused HIV patent

FDA approves first therapy to treat patients with rare blood disorder

Govt may extend anti-dumping duty on imports of Chinese chemical

GE Healthcare and Akeso Pharma to expedite novel therapy manufacturing in China

AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology

AstraZeneca announces three large-scale initiatives in China to advance global medicine research and development

Glenmark recalls over 2 lakh cartons of product in US

Punjab asks Centre to regulate price of buprenorphine under Essential Commodities Act

Phillips-Medisize Announced as Winner of 16th CPhI Pharma Award for Drug Delivery Devices

AstraZeneca's phase III OLYMPUS and ROCKIES trials show roxadustat significantly increases haemoglobin levels for CKD patients with anaemia

Aurobindo Pharma USA recalls Ranitidine over impurities

Chinese company in vaccine scandal declared bankrupt

Sun Pharma ex-employee alleges US Law violation, discrimination

Shilpa Medicare gets US FDA nod for Erlotinib tablets

Orsiro coronary DES receives market approval in China

Biocon’s $1-bn target for biologics biz achievable by FY22: Kiran Mazumdar Shaw

Johnson & Johnson files for European approval of Ebola vaccine

Takeda's dengue vaccine effective overall in study but with major limitation

Amgen to expand oncology presence in China

Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830

Abbott announces discovery of new strain of HIV, keeping global health community a step ahead of the virus

New FDA warning letters show India’s drugmakers still in trouble

Aurobindo’s buyout of Sandoz assets delayed on FTC query

Aeromics, Simcere team up for anti-edema therapy in Greater China

SignPath Pharma, Inc. Announces an Out-license Agreement of Its CorreQTTM Technology for Mitigation of QT Prolongation with Rain Therapeutics Inc.

Unique case of disease resistance reveals possible Alzheimer’s treatment

Chinese delegation visits Gujarat to explore bulk drug industry in India

CPhI Annual Report predicts Europe to surpass the USA in biologic manufacturing capacity by 2023

Raybow Pharmaceutical acquires PharmAgra Labs

Amgen inks collaboration with BeiGene to expand oncology presence in China

Merz Aesthetics introduces Ultherapy treatment to India

Novartis Cosentyx® shows encouraging results versus Humira® from first-of-its-kind head-to-head trial in psoriatic arthritis

FDA classifies Abbott's blood pumping system recall as most serious

AbbVie says multiple parties vying for assets related to Allergan deal approval

Merck loses bid to revive $2.54 bln patent verdict against Gilead

Novartis says delayed telling FDA of Zolgensma concern due to "mistake"

Tamil Nadu kids getting addicted to injectable drugs: NCPCR

China okays sale of first home-grown Alzheimer's drug

Qpex Biopharma, Brii Bio target MDR infections

Cyclo Therapeutics Signs Agreement with Worldwide Clinical Trials to Conduct Alzheimer’s Disease Clinical Trial

AstraZeneca sells European rights for schizophrenia drug to Cheplapharm

Cadila Healthcare gets EIR from USFDA for Baddi facility

FDA approves Biogen and Alkermes' multiple sclerosis drug

NeuroRx secures HK$ 750 M capital commitment

Dr Reddy's gets 4 observations from USFDA for Srikakulam plant

Macleods Pharma USA Inc recalls 31,968 bottles of diabetes drug in US

Mumbai pharma company gets licence for breakthrough TB drug

GlaxoSmithKline starts late-stage trial for experimental antibiotic

Novartis' key multiple sclerosis product Gilenya gets approval in China

Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics

US FDA approves Eton Pharma's Biorphen injection

AstraZeneca tops sales forecasts on China, new drug boosts

Aurobindo Pharma gets USFDA nod for its expectorant tablets

CST and Cell Press launch Cell Mentor in China

NGOs ask WHO to update Guidelines on Similar Biotherapeutic Products for facilitating access to new biologic medicines

Centre likely to cap veterinary drug prices

GSK gets FDA nod for wider use of ovarian cancer drug Zejula

U.S. FDA says carcinogen not found in alternatives of Zantac and its generics

New Horizon develops technology partnership with Prenetics

Lincoln Pharma receives Indian patent for Diclofenac Rectal Spray

Alembic gets USFDA nod for ointment to treat skin disease

GSK Pharma closes Q2 revenue up 8 pc at Rs 873 crore

Lupin gets USFDA nod to market its mania and epilepsy treatment drug in US